{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-012767","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.781267+00:00","generated_at":"2026-05-18T06:46:48.225700+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Medicus Pharma enters warrant inducement for $3.75M gross; also sells $1.52M shares via SEPA","bullets":["Holder exercises 1.34M existing warrants at $2.80; receives 2.68M new warrants at $3.75 expiring in 5 years.","Gross proceeds from warrant exercise ~$3.75M; net used for clinical trials, working capital, and Antev acquisition costs.","Company sold 490,000 common shares to Yorkville via SEPA for net proceeds of ~$1.52M at ~$3.10/share.","Maxim Group LLC receives 6.0% cash fee on warrant exercise gross proceeds.","Company to file S-1 registration for resale of new warrant shares within 120 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-012767","json":"https://secwatch.observer/filing/0001062993-25-012767.json","markdown":"https://secwatch.observer/filing/0001062993-25-012767.md","text":"https://secwatch.observer/filing/0001062993-25-012767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/0001062993-25-012767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:46:48.225700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}